open access

Vol 84, No 6 (2016)
EDITORIAL
Submitted: 2016-12-07
Accepted: 2016-12-07
Get Citation

Living better and longer with cystic fibrosis

Szczepan Cofta
DOI: 10.5603/ARM.2016.0039
·
Pubmed: 28009029
·
Adv Respir Med 2016;84(6):307-309.

open access

Vol 84, No 6 (2016)
EDITORIAL
Submitted: 2016-12-07
Accepted: 2016-12-07

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Living better and longer with cystic fibrosis

Journal

Advances in Respiratory Medicine

Issue

Vol 84, No 6 (2016)

Pages

307-309

DOI

10.5603/ARM.2016.0039

Pubmed

28009029

Bibliographic record

Adv Respir Med 2016;84(6):307-309.

Authors

Szczepan Cofta

References (14)
  1. Andersen DH. Cystic fibrosis of the pancreas and its relations to celiac disease: a clinical and pathologic study. Am J Dis Child. 1938; 56(2): 344–349.
  2. Simmonds N. Changing epidemiology: new challenges in cystic fibrosis.Simmonds N, Hubert D. ed. European Cystic Fibrosis Society, Denmark 2015: 9–26.
  3. Cystic Fibrosis Trust. Annual data report 2013. Bromley: Cystic Fibrosis Trust. cysticfibrosis.org.uk/ Registry (2014).
  4. Chatterjee K, Goyal A, Shah N, et al. Contemporary national trends of cystic fibrosis hospitalizations and co-morbidities in the United States. Adv Respir Med. 2016; 84(6): 316–323.
  5. Hassanzad M, Boloursaz MR, Darougar S, et al. Long term outcome of cystic fibrosis patients with multisystem evaluation. Adv Respir Med. 2016; 84(6): 310–315.
  6. Sobczyńska-Tomaszewska A, Ołtarzewski M, Czerska K, et al. NBS CF working group. Newborn screening for cystic fibrosis: Polish 4 years' experience with CFTR sequencing strategy. Eur J Hum Genet. 2013; 21(4): 391–396.
  7. Mahadeva R, Webb K, Westerbeek RC, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998; 316(7147): 1771–1775.
  8. Johnson C, Butler SM, Konstan MW, et al. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest. 2003; 123(1): 20–27.
  9. Smyth AR, Bell SC, Bojcin S, et al. European Cystic Fibrosis Society. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. J Cyst Fibros. 2014; 13 Suppl 1: S23–S42.
  10. Conveay S, Balfour IM, De Ri, et al. Standards of care for patients with cystic fibrosis: an European consensus. Framework for Cystic Fibrosis Centre. J Cyst Fibros . 2014; 13(Suppl 1): S3–S22.
  11. Saiman L, Siegel JD, LiPuma JJ, et al. Cystic Fibrous Foundation, Society for Healthcare Epidemiology of America. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol. 2014; 35 Suppl 1: S1–S67.
  12. Walkowiak J, Pogorzelski A, Sands D, et al. Zasady rozpoznawania i leczenia mukowiscydozy. Zalecenia Polskiego Towarzystwa Mukowiscydozy. Standardy Med Pediat. 2009; 6: 1–28.
  13. Flume PA, Anderson DL, Hardy KK, et al. Transition programs in cystic fibrosis centers: perceptions of pediatric and adult program directors. Pediatr Pulmonol. 2001; 31(6): 443–450.
  14. Tuchman LK, Schwartz LA, Sawicki GS, et al. Cystic fibrosis and transition to adult medical care. Pediatrics. 2010; 125(3): 566–573.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl